Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
News Analysis Trumps EEOC sues New York Times alleging discrimination against a White male e What drives KALA BIO KALA profit more than anything else Q4 2025 Profit Exceeds Views KSPI Joint stock proves resilient despite 155 percent EPS miss as investors search for silver lining Ramaco Resources METC Competitive Landscape Q4 2025 EPS Beats Forecasts TKO Group Director Invests Nearly 1 Million in Shares Highlighting Insider Confidence Magnificent Seven Earnings Surge Sparks Bubble Debate Mercury Achieves 52 Billion Valuation Amid Fintech Sector Resurgence Soaring Stocks May Face Rocky Patch as Earnings Wind Down and Yields Perk Up Maxim Group Reiterates Buy Rating on AB Science with 4 Target After FY2025 Results and Insurance Milestone BTS and OREO Unveil LimitedEdition Cookie Inspired by Korean Culture and ARMY Fandom Crown Crafts Inc CRWS Q1 2026 Earnings Reports EPS of 014 as Stock Gains WEN Q1 2026 Earnings EPS Surpasses Estimates by 241 as Value Initiatives Drive Profitability Lisata Therapeutics Q3 2025 Earnings NarrowerthanExpected Loss as Biotech Advances Clinical Pipeline Terex Corporation TEX Q1 2026 Earnings EPS Beats Estimates by 25 Amid Solid Execution COHN Q1 2026 Earnings EPS of 065 as Stock Edges Lower CPRT Q1 2026 Earnings EPS Surpasses Estimates as Stock Edges Lower SenesTech Inc SNES Edges Higher Approaching Key Resistance at 190 SVAQW Warrants Hold Steady at 031 Amid Consolidation Phase Lineage Inc LINE Rallies 2 as Stock Builds Momentum Above Key Support Dawson Geophysical DWSN Faces Pressure as Shares Decline Nearly 3 Fiverr FVRR Holds Steady Near Key Support as Stock Trades Flat RSG Q1 2026 Earnings EPS Beat Driven by Operational Efficiency FBIN Q1 2026 Earnings Narrow EPS Miss on Flat Revenue as Stock Advances ESI Q1 2026 Earnings EPS Beats Estimates Shares Gain Penumbra Q1 2026 Earnings EPS Misses Estimates Stock Slips but Holds Steady Prime Medicine Inc PRME Q1 2026 Earnings WiderthanExpected Loss Highlights PreRevenue Development Phase